ALFA Filings
Every announcement, straight from the exchange
Every Valiant Laboratories other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Valiant Laboratories Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Valiant Laboratories Limited has dispatched letters to shareholders who have not registered their email addresses, providing access to the Annual Report and 5th AGM notice.
Valiant Laboratories Limited submitted its Monitoring Agency Report for the quarter ended June 30, 2026, confirming the utilization of funds from its previous rights issue.
Valiant Laboratories filed its FY26 Annual Secretarial Compliance Report. The company paid a ₹0.02 Crore fine for a minor procedural delay regarding rights issue committee meetings.
Valiant Laboratories Limited is exploring potential restructuring options across its holding and subsidiary entities. The board aims to achieve strategic synergies and unlock long-term shareholder value.